Search

Author/Creator Heim, A.

2. Initial results from a phase 1 trial of OKI-179, an oral Class 1-selective depsipeptide HDAC inhibitor, in patients with advanced solid tumors. (October 2020)

Authors:
Diamond, J.; Gordon, G.; Kagihara, J.; Corr, B.; Lieu, C.; Pacheco, J.; Heim, A.; DeMattei, J.; Eckhardt, S.G.; Winkler, J.; Piscopio, A.
Journal:
European journal of cancer
Issue:
Volume 138(2020)Supplement 2
Page Start:
S12
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

4. Severe underquantification of HIV-1 group O isolates by major commercial PCR-based assays. (December 2020)

Authors:
Berger, A.; Muenchhoff, M.; Hourfar, K.; Kortenbusch, M.; Ambiel, I.; Stegmann, L.; Heim, A.; Sarrazin, C.; Ehret, R.; Daniel, V.; Wasner, M.; Plantier, J.-C.; Eberle, J.; Gürtler, L.; Haberl, A.E.; Stürmer, M.; Keppler, O.T.
Journal:
Clinical microbiology and infection
Issue:
Volume 26:Number 12(2020)
Page Start:
1688.e1
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗